BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25052387)

  • 1. Cost-utility analysis of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapy.
    Jódar-Sánchez F; Ortega F; Parra C; Gómez-Suárez C; Bonachela P; Leal S; Pérez P; Jordán A; Barrot E
    J Telemed Telecare; 2014 Sep; 20(6):307-16. PubMed ID: 25052387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.
    Henderson C; Knapp M; Fernández JL; Beecham J; Hirani SP; Cartwright M; Rixon L; Beynon M; Rogers A; Bower P; Doll H; Fitzpatrick R; Steventon A; Bardsley M; Hendy J; Newman SP;
    BMJ; 2013 Mar; 346():f1035. PubMed ID: 23520339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a telehealth programme for patients with severe chronic obstructive pulmonary disease treated with long-term oxygen therapy.
    Jódar-Sánchez F; Ortega F; Parra C; Gómez-Suárez C; Jordán A; Pérez P; Bonachela P; Leal S; Barrot E
    J Telemed Telecare; 2013 Jan; 19(1):11-7. PubMed ID: 23393057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis.
    Milne RJ; Hockey H; Rea H
    Value Health; 2014 Jun; 17(4):320-7. PubMed ID: 24968990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease.
    Oba Y
    Am J Manag Care; 2009 Feb; 15(2):97-104. PubMed ID: 19284806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium.
    Hettle R; Wouters H; Ayres J; Gani R; Kelly S; Lion M; Decramer M
    Respir Med; 2012 Dec; 106(12):1722-33. PubMed ID: 23040833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
    Hofer F; Achelrod D; Stargardt T
    Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain.
    Jódar-Sánchez F; Martín JJ; López del Amo MP; García L; Araújo-Santos JM; Epstein D
    J Am Geriatr Soc; 2014 Jul; 62(7):1272-80. PubMed ID: 24891096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease.
    Monninkhof E; van der Valk P; Schermer T; van der Palen J; van Herwaarden C; Zielhuis G
    Chron Respir Dis; 2004; 1(1):7-16. PubMed ID: 16281663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of a brief education, self-management and upper limb exercise training in people with rheumatoid arthritis (EXTRA) programme: a trial-based analysis.
    Manning VL; Kaambwa B; Ratcliffe J; Scott DL; Choy E; Hurley MV; Bearne LM
    Rheumatology (Oxford); 2015 Feb; 54(2):302-9. PubMed ID: 25173349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.
    Briggs AH; Lozano-Ortega G; Spencer S; Bale G; Spencer MD; Burge PS
    Value Health; 2006; 9(4):227-35. PubMed ID: 16903992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.
    Jódar-Sánchez F; Malet-Larrea A; Martín JJ; García-Mochón L; López Del Amo MP; Martínez-Martínez F; Gastelurrutia-Garralda MA; García-Cárdenas V; Sabater-Hernández D; Sáez-Benito L; Benrimoj SI
    Pharmacoeconomics; 2015 Jun; 33(6):599-610. PubMed ID: 25774017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
    Chiang CH
    Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept.
    Moayeri F; Dunt D; Hsueh YA; Doyle C
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):331-340. PubMed ID: 30324818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease.
    Sørensen SS; Pedersen KM; Weinreich UM; Ehlers L
    Appl Health Econ Health Policy; 2017 Jun; 15(3):413-424. PubMed ID: 27928660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.